![2050057-56-0,Upadacitinib hemihydrate,Upadacitinib hemihydrate;NEW4DV02U5;Upadacitinib hydrate (JAN);2050057-56-0;UPADACITINIB HYDRATE [JAN];(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1);1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-E)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-;Rinvoq (TN);UNII-NEW4DV02U5;UPADACITINIB HEMIHYDRATE [WHO-DD];D11048;1831899-73-0;rel-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1)](http://file1.lookchem.com/cas/2023/08/11/2050057-56-0.jpg)
Upadacitinib hemihydrate(2050057-56-0)
- CAS Registry Number:
- 2050057-56-0
- Synonyms:
- Upadacitinib hemihydrate;NEW4DV02U5;Upadacitinib hydrate (JAN);2050057-56-0;UPADACITINIB HYDRATE [JAN];(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1);1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-E)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-;Rinvoq (TN);UNII-NEW4DV02U5;UPADACITINIB HEMIHYDRATE [WHO-DD];D11048;1831899-73-0;rel-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1)
- Molecular Formula:
- C34H40F6N12O3
- Molecular Weight:
- 778.8
- EINECS:
CAS No.:2050057-56-0
Name: Upadacitinib hemihydrate
Related Suppliers
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione